Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1370172
European Journal of Endocrinology, Vol 137, Issue 2, 172-175
Copyright © 1997 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dickstein, G
Right arrow Articles by Shechner, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dickstein, G
Right arrow Articles by Shechner, C

Articles

One microgram is the lowest ACTH dose to cause a maximal cortisol response. There is no diurnal variation of cortisol response to submaximal ACTH stimulation

G Dickstein, D Spigel, E Arad, and C Shechner

Division of Endocrinology, Bnai Zion Medical Center, Haifa, Israel.

There are many suggestions in the literature that the adrenal gland is more sensitive to ACTH in the evening than in the morning. However, all these studies in humans were conducted when the basal cortisol level was not suppressed, and were based on the observation that, after stimulation, the increases in cortisol differed, though the peak values were the same. To examine this, we established the lowest ACTH dose that caused a maximal cortisol stimulation even when the basal cortisol was suppressed, and used a smaller dose of ACTH for morning and evening stimulation. The lowest ACTH dose to achieve maximal stimulation was found to be 1.0 microgram, with which dose cortisol concentration increased to 607.2 +/- 182 nmol/l, compared with 612.7 +/- 140.8 nmol/l with the 250 micrograms test (P > 0.3). The use of smaller doses of ACTH (0.8 and 0.6 microgram) achieved significantly lower cortisol responses (312 +/- 179.4 and 323 +/- 157.3 nmol/l respectively; both P < 0.01 compared with the 1 microgram test). When a submaximal ACTH dose (0.6 microgram) was used to stimulate the adrenal at 0800 and 1600 h, after pretreatment with dexamethasone, no difference in response was noted at either 15 min (372.6 +/- 116 compared with 394.7 +/- 129.7 nmol/l) or 30 min (397.4 +/- 176.6 compared with 403 +/- 226.3 nmol/l; P > 0.3 for both times). These results show that 1.0 microgram ACTH, used latterly as a low-dose test, is very potent in stimulating the adrenal, even when baseline cortisol is suppressed; smaller doses cause reduction of this potency. Our data show that there is probably no diurnal variation in the response of the adrenal to ACTH, if one eliminates the influence of the basal cortisol level and uses physiologic rather than superphysiologic stimuli.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
I. E. Widmer, J. J. Puder, C. Konig, H. Pargger, H. R. Zerkowski, J. Girard, and B. Muller
Cortisol Response in Relation to the Severity of Stress and Illness
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4579 - 4586.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E. O Johnson, T. C Kamilaris, A. E Calogero, P. W Gold, and G. P Chrousos
Experimentally-induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis
Eur. J. Endocrinol., July 1, 2005; 153(1): 177 - 185.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Abraham, J. Gottschalk, and F. R. Ungemach
Evidence for Ototopical Glucocorticoid-Induced Decrease in Hypothalamic-Pituitary-Adrenal Axis Response and Liver Function
Endocrinology, July 1, 2005; 146(7): 3163 - 3171.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
M. E. George, V. Sharma, J. Jacobson, S. Simon, and A. J. Nopper
Adverse Effects of Systemic Glucocorticosteroid Therapy in Infants With Hemangiomas
Arch Dermatol, August 1, 2004; 140(8): 963 - 969.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
E. S. Nylen and B. Muller
Endocrine Changes in Critical Illness
J Intensive Care Med, March 1, 2004; 19(2): 67 - 82.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Mancini, B. Kola, F. Mantero, and G. Arnaldi
Functional and Nonfunctional Adrenocortical Tumors Demonstrate a High Responsiveness to Low-Dose Adrenocorticotropin
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 1994 - 1998.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
J. Gaab, D. Huster, R. Peisen, V. Engert, V. Heitz, T. Schad, Th. Schurmeyer, and U. Ehlert
Assessment of Cortisol Response With Low-Dose and High-Dose ACTH in Patients With Chronic Fatigue Syndrome and Healthy Comparison Subjects
Psychosomatics, April 1, 2003; 44(2): 113 - 119.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Arvat, L. Di Vito, F. Lanfranco, M. Maccario, C. Baffoni, R. Rossetto, G. Aimaretti, F. Camanni, and E. Ghigo
Stimulatory Effect of Adrenocorticotropin on Cortisol, Aldosterone, and Dehydroepiandrosterone Secretion in Normal Humans: Dose-Response Study
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3141 - 3146.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Dickstein
Commentary to the Article: Comparison of Low and High Dose Corticotropin Stimulation Tests in Patients with Pituitary Diseasee
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4531 - 4532.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 European Society of Endocrinology.